Drug Facts in Media
The Netherlands, United States, Australia and New Zealand are consuming the highest amounts of designer 'party' drugs, according to wastewater samples taken from eight countries over the New Year period.
Study reveals the unintended and negative consequences of policies designed to reduce the supply of opioids in the population for overdose.
Recreational drinking, smoking, and drug use is linked to premature heart disease in young people, particularly younger women.
Researchers have developed experimental vaccines that have shown in rodents to blunt the deadly effects of fentanyl as well as its even more fatal cousin, carfentanil.
Nearly a third of US teens and young adults prescribed a psychoactive drug misuse that drug, with the likelihood of misuse rising with age, suggests an analysis of national survey responses.
Access to legal cannabis stores is associated with a reduction in opioid related deaths in the United States, particularly those linked to synthetic opioids such as fentanyl, finds a new study.
A recent study of drugged driving shows that a sizable percentage of individuals reported the use of marijuana and other illicit drugs while operating behind the wheel.
Teenagers with happy childhood memories are likely to drink less, take fewer drugs and enjoy learning, according to new research.
A combination of two medications, injectable naltrexone and oral bupropion, was safe and effective in treating adults with moderate or severe methamphetamine use disorder in a double-blind, placebo-controlled Phase III clinical trial. The findings suggest this combination therapy may be a promising addition to current approaches to treatment, such as cognitive behavioral therapy and contingency management interventions, for a very serious condition that remains difficult to treat and overcome.
Marijuana use increases throughout the calendar year, with use up 13 percent on average at the end of each year compared to the beginning.
Scientists have uncovered new evidence of the potential health risks of chemicals in tobacco and marijuana smoke.
More than half of people who use medical marijuana products to ease pain also experience clusters of multiple withdrawal symptoms when they're between uses, a new study finds. And about 10% of the patients taking part in the study experienced worsening changes to their sleep, mood, mental state, energy and appetite over the next two years as they continued to use cannabis.
Female rats that inhaled vaporized cannabis daily for a month developed a blunted physiological response to stress, according to a new study. In contrast, male rats that were provided access to the same potency of cannabis over the same 30-day window did not experience any physiological changes in how they responded to a stressful situation.
Made in clandestine laboratories and sold widely across the United States, the diverse class of drugs known as synthetic cannabinoids presents a growing public health threat. In a new study, scientists have devised a way to deactivate these designer drugs after they've been administered -- offering a potential path for treating addiction and overdose.
A non-hallucinogenic version of the psychedelic drug ibogaine, with potential for treating addiction, depression and other psychiatric disorders, has been developed by researchers.
Cocaine continues to be one of the most commonly abused illicit drugs in the United States. Pre-clinical literature suggests that targeting glucagon-like peptide-1 receptors (GLP-1Rs) in the brain may represent a novel approach to treating cocaine use disorder. Specifically, GLP-1R agonists, which are FDA-approved for treating diabetes and obesity, have been shown to reduce voluntary drug taking and seeking in preclinical models of cocaine used disorder.
A new study suggests that even low doses of glucocorticoid may increase the risk of cardiovascular diseases.
Cannabidiol (CBD) oils are equally or less effective at inhibiting the growth of certain cancer cells compared to pure CBD, according to researchers. The results of their recent study indicate that future research into the clinical applications of cannabinoids should include an analysis of whether the pure cannabinoid compound or intact plant material is more effective at achieving the therapeutic effect.
Largest study on how cannabis has changed over time finds increased strength putting consumers at greater risk of harm.